Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats

Gubinelli, F. LU ; Sarauskyte, L. LU ; Venuti, C. LU ; Kulacz, I. LU ; Cazzolla, G. LU ; Negrini, M. LU ; Anwer, D. LU ; Vecchio, I. ; Jakobs, F. and Manfredsson, F. P. , et al. (2023) In Current Research in Neurobiology 4.
Abstract

Background: In the last decades different preclinical animal models of Parkinson's disease (PD) have been generated, aiming to mimic the progressive neuronal loss of midbrain dopaminergic (DA) cells as well as motor and non-motor impairment. Among all the available models, AAV-based models of human alpha-synuclein (h-aSYN) overexpression are promising tools for investigation of disease progression and therapeutic interventions. Objectives: The goal with this work was to characterise the impairment in motor and non-motor domains following nigrostriatal overexpression of h-aSYN and correlate the behavioural deficits with histological assessment of associated pathology. Methods: Intranigral injection of an AAV9 expressing h-aSYN was... (More)

Background: In the last decades different preclinical animal models of Parkinson's disease (PD) have been generated, aiming to mimic the progressive neuronal loss of midbrain dopaminergic (DA) cells as well as motor and non-motor impairment. Among all the available models, AAV-based models of human alpha-synuclein (h-aSYN) overexpression are promising tools for investigation of disease progression and therapeutic interventions. Objectives: The goal with this work was to characterise the impairment in motor and non-motor domains following nigrostriatal overexpression of h-aSYN and correlate the behavioural deficits with histological assessment of associated pathology. Methods: Intranigral injection of an AAV9 expressing h-aSYN was compared with untreated animals, 6-OHDA and AAV9 expressing either no transgene or GFP. The animals were assessed on a series of simple and complex behavioural tasks probing motor and non-motor domains. Post-mortem neuropathology was analysed using immunohistochemical methods. Results: Overexpression of h-aSYN led to progressive degeneration of DA neurons of the SN and axonal terminals in the striatum (STR). We observed extensive nigral and striatal pathology, resembling that of human PD brain, as well as the development of stable progressive deficit in simple motor tasks and in non-motor domains such as deficits in motivation and lateralised neglect. Conclusions: In the present work we characterized a rat model of PD that closely resembles human PD pathology at the histological and behavioural level. The correlation of cell loss with behavioural performance enables the selection of rats which can be used in neuroprotective or neurorestorative therapies.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
AAV, Alpha-synuclein, Choice reaction time, Parkinson's disease, Visuo-spatial neglect
in
Current Research in Neurobiology
volume
4
article number
100065
publisher
Elsevier
external identifiers
  • pmid:36632447
  • scopus:85159466237
ISSN
2665-945X
DOI
10.1016/j.crneur.2022.100065
language
English
LU publication?
yes
additional info
Publisher Copyright: © 2022 The Authors
id
1da8d493-7ad1-4995-8a9e-fd65c26e3f54
date added to LUP
2024-01-15 11:44:22
date last changed
2024-04-15 22:29:37
@article{1da8d493-7ad1-4995-8a9e-fd65c26e3f54,
  abstract     = {{<p>Background: In the last decades different preclinical animal models of Parkinson's disease (PD) have been generated, aiming to mimic the progressive neuronal loss of midbrain dopaminergic (DA) cells as well as motor and non-motor impairment. Among all the available models, AAV-based models of human alpha-synuclein (h-aSYN) overexpression are promising tools for investigation of disease progression and therapeutic interventions. Objectives: The goal with this work was to characterise the impairment in motor and non-motor domains following nigrostriatal overexpression of h-aSYN and correlate the behavioural deficits with histological assessment of associated pathology. Methods: Intranigral injection of an AAV9 expressing h-aSYN was compared with untreated animals, 6-OHDA and AAV9 expressing either no transgene or GFP. The animals were assessed on a series of simple and complex behavioural tasks probing motor and non-motor domains. Post-mortem neuropathology was analysed using immunohistochemical methods. Results: Overexpression of h-aSYN led to progressive degeneration of DA neurons of the SN and axonal terminals in the striatum (STR). We observed extensive nigral and striatal pathology, resembling that of human PD brain, as well as the development of stable progressive deficit in simple motor tasks and in non-motor domains such as deficits in motivation and lateralised neglect. Conclusions: In the present work we characterized a rat model of PD that closely resembles human PD pathology at the histological and behavioural level. The correlation of cell loss with behavioural performance enables the selection of rats which can be used in neuroprotective or neurorestorative therapies.</p>}},
  author       = {{Gubinelli, F. and Sarauskyte, L. and Venuti, C. and Kulacz, I. and Cazzolla, G. and Negrini, M. and Anwer, D. and Vecchio, I. and Jakobs, F. and Manfredsson, F. P. and Davidsson, M. and Heuer, A.}},
  issn         = {{2665-945X}},
  keywords     = {{AAV; Alpha-synuclein; Choice reaction time; Parkinson's disease; Visuo-spatial neglect}},
  language     = {{eng}},
  publisher    = {{Elsevier}},
  series       = {{Current Research in Neurobiology}},
  title        = {{Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats}},
  url          = {{http://dx.doi.org/10.1016/j.crneur.2022.100065}},
  doi          = {{10.1016/j.crneur.2022.100065}},
  volume       = {{4}},
  year         = {{2023}},
}